about
The molecular basis of lung cancer: molecular abnormalities and therapeutic implicationsQuantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complexEffect of Paris saponin I on radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line.Targeted Therapies in Lung Cancer.High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications.Mass spectrometry-based proteomic profiling of lung cancer.Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapy.Mesenchymal stem cells as vectors for lung diseaseExhaled pentane as a possible marker for survival and lipid peroxidation during radiotherapy for lung cancer--a pilot study.A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin
P2860
Q24802445-19BFA313-534C-4771-8787-2E6E003112B2Q28536191-FA02CE90-87EB-40C6-8A8B-2BD663F7729CQ33727478-8EC44303-D0BF-4E1E-B9D5-8FF8A2EFDBCAQ34030379-B4CFC4FE-CFFF-4555-9463-D33A9CE5522EQ36288148-62A24D02-C816-4018-AE09-AB44135B7412Q37171914-274B7542-3D5C-4A32-9DF3-F3EF595B6366Q37214261-418C81B8-0CC6-41D2-8342-D39FE9C85D19Q37236694-E05C45CA-846E-4BE5-A07D-2E8892BC5B8FQ43294336-DE93A9C8-115E-40CE-A314-9DEFB3952883Q45949842-502B4267-8E4B-48CE-ADE6-959609782864Q58799114-97A5077A-113F-4375-81E3-C203B514EB2B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical impact of novel treatment strategies.
@ast
Clinical impact of novel treatment strategies.
@en
Clinical impact of novel treatment strategies.
@nl
type
label
Clinical impact of novel treatment strategies.
@ast
Clinical impact of novel treatment strategies.
@en
Clinical impact of novel treatment strategies.
@nl
prefLabel
Clinical impact of novel treatment strategies.
@ast
Clinical impact of novel treatment strategies.
@en
Clinical impact of novel treatment strategies.
@nl
P2860
P356
P1433
P1476
Clinical impact of novel treatment strategies.
@en
P2093
Giuseppe Giaccone
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205565
P407
P577
2002-10-01T00:00:00Z
P5875
P6179
1017010624